REGENERON PHARMACEUTICALS (1REGN.MI) Earnings History & Surprises

BIT:1REGN • US75886F1075

Current stock price

667.6 EUR
+39.4 (+6.27%)
Last:

1REGN.MI Earnings overview

Past quarterly earnings results for REGENERON PHARMACEUTICALS (1REGN.MI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Feb 2, 2026
Period
Q4 / 2025
EPS Estimate
$10.77
Revenue Estimate
3.84B

Last Reported

Most Recent
Release Date
Oct 28, 2025
Period
Q3 / 2025
EPS Reported
$11.83
EPS Surprise
20.96%
Revenue Surprise
2.66%

Beat Rate

Last 8 Quarters
63%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 11.83 9.78 20.96% -5.06% 3.754B 3.657B 2.66% 0.90%
Q2 2025 12.89 8.61 49.77% 11.51% 3.676B 3.35B 9.72% 3.62%
Q1 2025 8.22 9.00 -8.66% -13.93% 3.029B 3.34B -9.31% -3.69%
Q4 2024 12.07 11.50 4.93% 1.77% 3.789B 3.824B -0.91% 10.34%
Q3 2024 12.46 11.93 4.48% 7.51% 3.721B 3.744B -0.62% 10.65%
Q2 2024 11.56 10.83 6.79% 12.89% 3.547B 3.446B 2.93% 12.32%
Q1 2024 9.55 10.29 -7.23% -5.35% 3.145B 3.284B -4.23% -0.54%
Q4 2023 11.86 10.95 8.36% -5.57% 3.434B 3.351B 2.48% 0.57%
Q3 2023 11.59 10.93 6.01% 4.04% 3.363B 3.298B 1.96% 14.53%
Q2 2023 10.24 10.04 1.99% 4.81% 3.158B 3.077B 2.64% 10.53%
Q1 2023 10.09 9.75 3.50% 12.99% 3.162B 3.06B 3.34% 6.64%
Q4 2022 12.56 10.23 22.77% -41.09% 3.414B 3.188B 7.10% -31.05%
Q3 2022 11.14 9.67 15.25% -22.48% 2.936B 2.926B 0.35% -14.96%
Q2 2022 9.77 9.02 8.33% -62.13% 2.857B 2.852B 0.18% -44.40%
Q1 2022 8.93 9.93 -10.09% -9.71% 2.965B 2.779B 6.70% 17.26%
Q4 2021 21.32 18.71 13.93% 123.71% 4.952B 4.598B 7.69% 104.37%
Q3 2021 14.37 10.31 39.43% 71.89% 3.453B 2.873B 20.18% 50.51%
Q2 2021 25.80 17.88 44.32% 260.34% 5.139B 3.995B 28.62% 163.24%
Q1 2021 9.89 9.18 7.72% 49.85% 2.529B 2.602B -2.82% 38.32%
Q4 2020 9.53 8.56 11.32% - 2.423B 2.471B -1.95% -
Q3 2020 8.36 7.28 14.87% - 2.294B 2.13B 7.70% -
Q2 2020 7.16 6.10 17.32% - 1.952B 1.777B 9.85% -
Q1 2020 6.60 6.25 5.53% - 1.828B 1.793B 1.96% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

1REGN.MI EPS Q2Q Growth1REGN.MI EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 100 200

Revenue Historical Q2Q growth and Acceleration

1REGN.MI Revenue Q2Q Growth1REGN.MI Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 50 100 150

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
16.75%
Max EPS beat (4)
49.77%
Min EPS beat (4)
-8.66%

Revenue beat statistics

Revenue beat (4)
2
Average Revenue beat (4)
0.54%
Max Revenue beat (4)
9.72%
Min Revenue beat (4)
-9.31%

Analysis

In the last 4 quarters, 1REGN.MI has beaten EPS estimates in 3 out of 4 releases
1REGN.MI has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, 1REGN.MI has beaten the EPS estimates by 16.7% on average.
In the last 4 quarters, 1REGN.MI has beaten the revenue estimates by 0.5% on average.
1REGN.MI Overview 1REGN.MI Technical Analysis Report 1REGN.MI Fundamental Analysis Report 1REGN.MI Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

REGENERON PHARMACEUTICALS / 1REGN.MI Earnings FAQ

Can you provide the last earnings date for REGENERON PHARMACEUTICALS?

REGENERON PHARMACEUTICALS (1REGN.MI) last reported earnings on 10/28/2025.

Did REGENERON PHARMACEUTICALS (1REGN.MI) beat earnings estimates last quarter?

REGENERON PHARMACEUTICALS (1REGN.MI) beat EPS estimates and beat revenue estimates in the most recent quarter.

What percentage of the time does 1REGN stock beat earnings estimates?

In the last 4 quarters, REGENERON PHARMACEUTICALS (1REGN.MI) has beaten EPS estimates in 3 out of 4 releases.